Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 2
1929 1
1932 1
1941 1
1945 2
1946 1
1947 5
1948 2
1950 4
1951 4
1952 4
1953 4
1954 6
1955 6
1956 9
1957 1
1958 1
1959 4
1960 4
1961 2
1962 3
1963 4
1964 2
1965 3
1966 11
1967 6
1968 8
1969 7
1970 8
1971 9
1972 11
1973 5
1974 8
1975 18
1976 15
1977 13
1978 13
1979 21
1980 20
1981 14
1982 23
1983 21
1984 19
1985 17
1986 22
1987 29
1988 28
1989 36
1990 36
1991 15
1992 18
1993 16
1994 16
1995 17
1996 17
1997 13
1998 9
1999 19
2000 18
2001 24
2002 23
2003 16
2004 15
2005 15
2006 29
2007 27
2008 33
2009 35
2010 31
2011 48
2012 53
2013 51
2014 56
2015 46
2016 54
2017 59
2018 56
2019 66
2020 76
2021 83
2022 68
2023 59
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,562 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism. Bilezikian JP, et al. Among authors: clarke bl. J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36245251 Free article. Review.
Hypoparathyroidism.
Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM. Mannstadt M, et al. Among authors: clarke bl. Nat Rev Dis Primers. 2017 Aug 31;3:17055. doi: 10.1038/nrdp.2017.55. Nat Rev Dis Primers. 2017. PMID: 28857066 Review.
Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.
Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. Minisola S, et al. Among authors: clarke bl. J Bone Miner Res. 2022 Nov;37(11):2315-2329. doi: 10.1002/jbmr.4665. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36245271 Free PMC article. Review.
Epidemiology and Diagnosis of Hypoparathyroidism.
Clarke BL, Brown EM, Collins MT, Jüppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV. Clarke BL, et al. J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99. doi: 10.1210/jc.2015-3908. Epub 2016 Mar 4. J Clin Endocrinol Metab. 2016. PMID: 26943720 Free PMC article. Review.
Management of Hypoparathyroidism: Summary Statement and Guidelines.
Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT Jr. Brandi ML, et al. Among authors: clarke bl. J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83. doi: 10.1210/jc.2015-3907. Epub 2016 Mar 4. J Clin Endocrinol Metab. 2016. PMID: 26943719 Review.
Inhibiting fatty acid synthesis overcomes colistin resistance.
Carfrae LA, Rachwalski K, French S, Gordzevich R, Seidel L, Tsai CN, Tu MM, MacNair CR, Ovchinnikova OG, Clarke BR, Whitfield C, Brown ED. Carfrae LA, et al. Among authors: clarke br. Nat Microbiol. 2023 Jun;8(6):1026-1038. doi: 10.1038/s41564-023-01369-z. Epub 2023 May 1. Nat Microbiol. 2023. PMID: 37127701
Gynecologic Pathology.
Clarke BA, McCluggage WG. Clarke BA, et al. Surg Pathol Clin. 2016 Jun;9(2):ix-x. doi: 10.1016/j.path.2016.04.001. Surg Pathol Clin. 2016. PMID: 27241113 No abstract available.
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L. Khan AA, et al. Among authors: clarke bl. J Bone Miner Res. 2023 Jan;38(1):14-25. doi: 10.1002/jbmr.4726. Epub 2022 Nov 12. J Bone Miner Res. 2023. PMID: 36271471 Free PMC article. Clinical Trial.
1,562 results